These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
181 related items for PubMed ID: 9825227
1. Induction of iNOS gene expression by monophosphoryl lipid A: a pharmacological approach for myocardial adaptation to ischemia. Maulik N, Tosaki A, Elliott GT, Maulik G, Das DK. Drugs Exp Clin Res; 1998; 24(3):117-24. PubMed ID: 9825227 [Abstract] [Full Text] [Related]
2. Preconditioning of rat heart with monophosphoryl lipid A: a role for nitric oxide. Tosaki A, Maulik N, Elliott GT, Blasig IE, Engelman RM, Das DK. J Pharmacol Exp Ther; 1998 Jun; 285(3):1274-9. PubMed ID: 9618433 [Abstract] [Full Text] [Related]
3. Role of inducible nitric oxide synthase in pharmacological "preconditioning" with monophosphoryl lipid A. Zhao L, Weber PA, Smith JR, Comerford ML, Elliott GT. J Mol Cell Cardiol; 1997 Jun; 29(6):1567-76. PubMed ID: 9220342 [Abstract] [Full Text] [Related]
4. Pharmacological preconditioning with monophosphoryl lipid A improves post ischemic diastolic function and modifies TNF-alpha synthesis. Sharony R, Frolkis I, Froylich D, Wildhirt SM, Shapira I, Reichart B, Nesher N, Uretzky G. Eur J Cardiothorac Surg; 2005 Mar; 27(3):501-7. PubMed ID: 15740963 [Abstract] [Full Text] [Related]
5. Selective modulation of endogenous nitric oxide formation in ischemia/reperfusion injury in isolated rat hearts--effects on regional myocardial flow and enzyme release. Han H, Kaiser R, Hu K, Laser M, Ertl G, Bauersachs J. Basic Res Cardiol; 2003 May; 98(3):165-74. PubMed ID: 12883834 [Abstract] [Full Text] [Related]
6. Nitric oxide-dependent mechanism of anti-ischemic myocardial protection induced by monophosphoryl lipid A. Xi L. Zhongguo Yao Li Xue Bao; 1999 Oct; 20(10):865-71. PubMed ID: 11270982 [Abstract] [Full Text] [Related]
7. Preservation of global cardiac function in the rabbit following protracted ischemia/reperfusion using monophosphoryl lipid A (MLA). Zhao L, Kirsch CC, Hagen SR, Elliott GT. J Mol Cell Cardiol; 1996 Jan; 28(1):197-208. PubMed ID: 8745227 [Abstract] [Full Text] [Related]
8. Delayed endothelial protective effects of monophosphoryl lipid A after myocardial ischemia and reperfusion in rats. Richard V, Danielou E, Kaeffer N, Thuillez C. J Mol Cell Cardiol; 1999 May; 31(5):1117-23. PubMed ID: 10336849 [Abstract] [Full Text] [Related]
9. Inhibition of iNOS protects the aging heart against beta-adrenergic receptor stimulation-induced cardiac dysfunction and myocardial ischemic injury. Li D, Qu Y, Tao L, Liu H, Hu A, Gao F, Sharifi-Azad S, Grunwald Z, Ma XL, Sun JZ. J Surg Res; 2006 Mar; 131(1):64-72. PubMed ID: 16154595 [Abstract] [Full Text] [Related]
10. Preconditioning of swine heart with monophosphoryl lipid A improves myocardial preservation. Yoshida T, Engelman RM, Engelman DT, Rousou JA, Maulik N, Sato M, Elliott GT, Das DK. Ann Thorac Surg; 2000 Sep; 70(3):895-900. PubMed ID: 11016330 [Abstract] [Full Text] [Related]
11. Critical timing of L-arginine treatment in post-ischemic myocardial apoptosis-role of NOS isoforms. Liang F, Gao E, Tao L, Liu H, Qu Y, Christopher TA, Lopez BL, Ma XL. Cardiovasc Res; 2004 Jun 01; 62(3):568-77. PubMed ID: 15158149 [Abstract] [Full Text] [Related]
12. Interleukin-1 alpha preconditioning reduces myocardial ischemia reperfusion injury. Maulik N, Engelman RM, Wei Z, Lu D, Rousou JA, Das DK. Circulation; 1993 Nov 01; 88(5 Pt 2):II387-94. PubMed ID: 8222183 [Abstract] [Full Text] [Related]
13. Late protective effect of pharmacological preconditioning with total flavones of rhododendra against myocardial ischemia-reperfusion injury. Zhang JH, Chen ZW, Wu Z. Can J Physiol Pharmacol; 2008 Mar 01; 86(3):131-8. PubMed ID: 18418440 [Abstract] [Full Text] [Related]
14. Role of platelet activating factor in cardiac dysfunction, apoptosis and nitric oxide synthase mRNA expression in the ischemic-reperfused rabbit heart. Loucks EB, Godin DV, Walley KR, McManus BM, Rahimian R, Granville DJ, Hong JM, Aktary FM, Qayumi AK. Can J Cardiol; 2003 Mar 15; 19(3):267-74. PubMed ID: 12677282 [Abstract] [Full Text] [Related]
15. [Myocardial ischemic reperfusion injury affected by the isozymes of nitric oxide synthase and their gene expression: experimental study]. Cui S, Zhu H. Zhonghua Yi Xue Za Zhi; 1998 May 15; 78(5):327-30. PubMed ID: 10923431 [Abstract] [Full Text] [Related]
16. Ischemic preconditioning upregulates inducible nitric oxide synthase in cardiac myocyte. Wang Y, Guo Y, Zhang SX, Wu WJ, Wang J, Bao W, Bolli R. J Mol Cell Cardiol; 2002 Jan 15; 34(1):5-15. PubMed ID: 11812160 [Abstract] [Full Text] [Related]
17. Effects of quercetin on gene and protein expression of NOX and NOS after myocardial ischemia and reperfusion in rabbit. Wan LL, Xia J, Ye D, Liu J, Chen J, Wang G. Cardiovasc Ther; 2009 Jan 15; 27(1):28-33. PubMed ID: 19207477 [Abstract] [Full Text] [Related]
18. [Simvastatin and ischemia-reperfusion damage: its effects on apoptotic myocyte death and on the endothelial expression of nitric-oxide synthetase in an experimental model of the isolated rat heart]. Di Napoli P, Maggi A, Spina R, Barsotti L, Taccardi AA, Stuppia L, Vianale G, Palka G, Barsotti A. Cardiologia; 1999 Jan 15; 44(1):69-74. PubMed ID: 10188333 [Abstract] [Full Text] [Related]
19. [Morphine-induced late cardioprotection: potential role of inducible nitric oxide synthase]. Shi EY, Jiang XJ, Bai H, Nakajima Y. Zhonghua Yi Xue Za Zhi; 2004 Jun 02; 84(11):891-5. PubMed ID: 15329271 [Abstract] [Full Text] [Related]